Since last Summer, Investindustrial has closed three acquisitions in the fertility clinics sector in Italy through its portfolio company GeneraLife, a group that has become one of the main players in fertility clinics in Europe in just 18 months (see the press release here).
After the first acquisition of Ginefiv in Spain in April 2019 and of FertiCare in the Czech Republic in August 2019, GenerLife bought Carl von Linnékliniken, based in Uppsala, the main fertility clinic in Sweden, last October, while in Italy acquired the Genera group last July, with headquarters in Rome and offices also in Perugia, Vicenza and Naples; Livet, the main private fertility clinic in Turin, in August; and finally, last October, Demetra, one of the major Tuscan fertility clinics, with offices in Florence and Grosseto.
Thanks to these acquisitions, today GeneraLife boasts a pro-forma turnover of over 40 million euros, includes 12 clinics and several satellite and counseling centers, carries out more than 15,000 treatments per year and employs more than 350 doctors and other healthcare professionals. health care.
The company is led by the managing director Marcos Bueso and by the scientific directors Laura Rienzi and Filippo Maria Ubaldi, two of the most recognized experts in assisted reproduction at the international level. GeneraLife aims to close new acquisitions in the future, in order to consolidate the fragmented sector of fertility clinics.
Marcos Bueso, ceo of GeneraLife., Commented: “GeneraLife has combined decades of medical and scientific experience with the support and leadership of an experienced management team, and its creation represents a historic milestone in the field of assisted reproduction. in Europe. The company has a concentration of talent and knowledge in reproductive medicine that cannot be found elsewhere in Europe. We are committed to adapting the treatment that best suits the needs of each patient, using the best technologies, procedures and techniques available and seeking continuously to maximize success rates. ”
Filippo Maria Ubaldi and Laura Rienzi, scientific directors of GeneraLife, added: “The creation of GeneraLife, which enhances proximity to patients with the guarantee of a common treatment quality, represents an important event for all European patients. using the best technologies and thanks to our continuous scientific research, we can guarantee patients high quality care and maximum safety “.
We recall that Investindustrial Acquisition Corp, the Spac sponsored by Investindustrial and listed on the NYSE since last November 19, has just closed the placement in recent days, reaching 402.5 million dollars of funds raised from investors, after the overallotment option was fully exercised (see here a previous article by BeBeez). Given that Investindustrial with a forward purchase agreement has undertaken to purchase up to 25 million shares of Spac at a price of 10 dollars per share for a maximum total of 250 million dollars, in a private placement operation that will close at the same time at the closing of the business combination (see here a previous article by BeBeez), then the total size of the Spac could therefore reach 652.5 million dollars.
Investindustrial VII, a fund managed by Investindustrial, last July granted a 600 million euro credit line linked to ESG parameters (see here a previous article by BeBeez). Investindustrial VII at the end of 2019 had raised 3.75 billion euros from investors (see here a previous article by BeBeez). We recall that last June a subsidiary of the fund purchased newly issued convertible preferred shares for $ 164 million of Knoll, an interior furniture group listed on Wall Street (see here a previous article by BeBeez). The deal on Knoll was conducted by an investment vehicle controlled by the same Investindustrial VII fund, dedicated to the Strategic Capital Investments sub-strategy, with a focus on listed companies. This vehicle had previously acquired 4.9% of Knoll on the market.
Investindustrial is an independently managed European investment, holding and advisory group with € 11 billion in funds raised. For over 30 years, the company has provided mid-market companies with capital, industrial expertise, operational support and a global platform to accelerate the creation of sustainable value and their international expansion.